簡(jiǎn)要描述:10-deacetyl-7-xylosyl Paclitaxel介紹:IUPAC/Chemical Name: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-6,11-dihydroxy-4a,8,13,13-tetramethyl
Synonym: 10-deacetyl-7-xylosyl Paclitaxel;
IUPAC/Chemical Name: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-6,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-4-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate
InChi Key: ORKLEZFXASNLFJ-DYLQFHMVSA-N
InChi Code: InChI=1S/C50H57NO17/c1-25-31(65-45(61)38(56)35(27-15-9-6-10-16-27)51-43(59)28-17-11-7-12-18-28)22-50(62)42(67-44(60)29-19-13-8-14-20-29)40-48(5,41(58)37(55)34(25)47(50,3)4)32(21-33-49(40,24-64-33)68-26(2)52)66-46-39(57)36(54)30(53)23-63-46/h6-20,30-33,35-40,42,46,53-57,62H,21-24H2,1-5H3,(H,51,59)/t30-,31+,32+,33-,35+,36+,37-,38-,39-,40+,42+,46+,48-,49+,50-/m1/s1
SMILES Code: C[C@@]1([C@@]([H])([C@@](CO2)(OC(C)=O)[C@]2(C[C@@H]1O[C@@]([H])([C@H](O)[C@H]3O)OC[C@H]3O)[H])[C@@H]4OC(C5=CC=CC=C5)=O)C([C@H](O)C6=C([C@H](C[C@@]4(C6(C)C)O)OC([C@@H]([C@@H](NC(C7=CC=CC=C7)=O)C8=CC=CC=C8)O)=O)C)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
10-deacetyl-7-xylosyl Paclitaxel
MedKoo 是超高質(zhì)量的實(shí)驗室藥物供應商。它于2009年由獲得博士學(xué)位的Qingqi Chen博士創(chuàng )立。北京大學(xué)合成化學(xué)專(zhuān)業(yè),并在約翰內斯-開(kāi)普勒大學(xué)林茨(與 Heinz Falk 博士)、內華達里諾大學(xué)(與 David Lightner 博士)和不列顛哥倫比亞大學(xué)(與 David Dolphin 博士)接受博士后培訓。
MedKoo 在美國北卡羅來(lái)納州設有有機合成實(shí)驗室,可以處理高挑戰性藥物的合成。公司主要產(chǎn)品為小分子抗癌試劑、激酶抑制劑和其它相關(guān)化學(xué)品。目前,MedKoo擁有超過(guò)15000種庫存產(chǎn)品,提供超過(guò)50000種小分子藥物和生化品,提供高挑戰性藥物的定制合成。
微信掃一掃